BEAM THERAPEUTICS INC shareholders Q2 2022

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 204 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.

BEAM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Rafferty Asset Management, LLC 120,973$4,683,0000.04%
Quantbot Technologies LP 11,300$437,0000.04%
GSA CAPITAL PARTNERS LLP 6,707$260,0000.04%
GUGGENHEIM CAPITAL LLC 96,939$3,752,0000.03%
Candriam S.C.A. 79,665$3,084,0000.02%
Tekla Capital Management LLC 15,817$612,0000.02%
SteelPeak Wealth, LLC 8,109$314,0000.02%
Schonfeld Strategic Advisors LLC 57,900$2,242,0000.02%
Mirae Asset Global Investments Co., Ltd. 213,007$8,245,0000.02%
Tower Research Capital LLC (TRC) 24,182$936,0000.02%
Squarepoint Ops LLC 90,898$3,519,0000.02%
FMR LLC 4,800,099$185,812,0000.02%
SCHRODER INVESTMENT MANAGEMENT GROUP 278,504$11,257,0000.02%
Avidian Wealth Solutions, LLC 6,100$236,0000.02%
PROFUND ADVISORS LLC 6,652$257,0000.02%
Man Group plc 93,309$3,612,0000.02%
AllSquare Wealth Management LLC 560$22,0000.02%
Renaissance Technologies 279,900$10,835,0000.01%
SG Americas Securities, LLC 28,183$1,091,0000.01%
CWM, LLC 36,912$1,429,0000.01%
External links

This page lists BEAM THERAPEUTICS INC's shareholders in Q2 2022. To view BEAM THERAPEUTICS INC's shareholder history, click here.